NHS National Framework for Transition products (Axitinib and Eltrombopag)

Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025 Offer reference number: CM/TNS/25/5722 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5722/01 Axitinib and Eltrombopag Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months) Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months) Lot 3 NW...